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Abstract
Pancreatic islet transplantation still represents a promising thera-
peutic strategy for curative treatment of type 1 diabetes mellitus.
However, a limited number of organ donors and insufficient vascu-
larization with islet engraftment failure restrict the successful
transfer of this approach into clinical practice. To overcome these
problems, we herein introduce a novel strategy for the generation
of prevascularized islet organoids by the fusion of pancreatic islet
cells with functional native microvessels. These insulin-secreting
organoids exhibit a significantly higher angiogenic activity
compared to freshly isolated islets, cultured islets, and non-prevas-
cularized islet organoids. This is caused by paracrine signaling
between the b-cells and the microvessels, mediated by insulin
binding to its corresponding receptor on endothelial cells. In vivo,
the prevascularized islet organoids are rapidly blood-perfused
after transplantation by the interconnection of their autochtho-
nous microvasculature with surrounding blood vessels. As a conse-
quence, a lower number of islet grafts are required to restore
normoglycemia in diabetic mice. Thus, prevascularized islet orga-
noids may be used to improve the success rates of clinical islet
transplantation.
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Introduction
The development of the Edmonton protocol, a glucocorticoid-free
immunosuppressive regimen, represents a milestone in clinical
pancreatic islet transplantation (Shapiro et al, 2000). Since then, the
rate of islet transplantation activity has increased all over the world
(Shapiro et al, 2003). However, multiple donors are still required to
achieve insulin independence. This is mainly due to the fact that the
isolation procedure strips the dense microvascular network of islets
(Brissova & Powers, 2008), leading to their failed engraftment after
transplantation (Gamble et al, 2018).
Significant research efforts have been conducted to promote the
revascularization and, thus, to improve nutrient and oxygen supply
of grafted islets during the first post-transplantational days (Song
et al, 2019; Menger et al, 2020). A promising strategy to achieve this
is the prevascularization of the transplantation site, as already
described for subcutaneous tissue by means of a catheter technique
(Pepper et al, 2015). However, in this case the revascularization of
the islet grafts is crucially dependent on the angiogenic ingrowth of
new microvessels from the surrounding host tissue, which is still a
time-consuming process. Another promising strategy is the incorpo-
ration or co-transplantation of endothelial cells (Song et al, 2010; Pan
et al, 2011; Oh et al, 2013; Barba-Gutierrez et al, 2016). However, the
isolation of primary endothelial cells out of different tissues (Hewett,
2016) or the generation of pluripotent stem cell-derived endothelial
cells (Ikuno et al, 2017) are not feasible approaches in daily clinical
practice, yet. Moreover, the development of new blood vessels origi-
nating from single endothelial cells requires up to 10 days (Laschke
& Menger, 2016), which is not fast enough to guarantee the survival
of islets in the initial phase after transplantation. To overcome this
problem, we herein introduce a novel strategy for the generation of
prevascularized islet organoids by the fusion of pancreatic islet cells
with microvascular fragments (MVF).
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Microvascular fragments are functional segments of arterioles,
capillaries, and venules with a length of 20–180 µm, which can be
enzymatically isolated in large amounts from adipose tissue within
a short period of time (Hoying et al, 1996; Pilia et al, 2014; Laschke
& Menger, 2015). They still exhibit the physiological morphology of
native microvessels, consisting of an endothelial cell-lined lumen
covered by stabilizing a-smooth muscle actin (SMA)-positive cells
(Hoying et al, 1996). Moreover, MVF release numerous angiogenic
growth factors, including vascular endothelial growth factor (VEGF)
and basic fibroblast growth factor (bFGF) (Pilia et al, 2014). They
are characterized by a high proliferative activity and rapidly
reassemble into blood-perfused microvascular networks by inter-
connecting with each other and the surrounding microvasculature
after transplantation (McDaniel et al, 2014). Accordingly, MVF have
been suggested as potent vascularization units for tissue engineering
and regenerative medicine (Laschke & Menger, 2015; Später et al,
2017; Frueh et al, 2017a; Frueh et al, 2017b).
Based on these findings, we speculated that the incorporation of
MVF into islet organoids markedly improves the constructs’ in vivo
vascularization capacity. To prove our hypothesis, we fused MVF
with mouse or human pancreatic islet cells to generate prevascular-
ized islet organoids (PI + MVF). These PI + MVF showed a mark-
edly improved in vivo vascularization, viability, and functionality
when compared to controls. Hence, the present proof-of-principle
study introduces a highly promising tissue engineering concept for
the treatment of type 1 diabetes (T1D).
Results
Generation of prevascularized islet organoids
We isolated islets from donor mouse pancreata by collagenase
digestion and further dissociated these islets into single cells by a
second enzymatic digestion step (Fig 1A). In addition, we harvested
the epididymal fat pads from male mice and processed the adipose
tissue mechanically and enzymatically to obtain a mixture of MVF
and extracellular matrix (ECM) (Fig 1B). This mixture was then fil-
trated to gain purified individual MVF (Fig 1B). We next character-
ized MVF by means of Western blot analysis using murine and
human endothelial cell lines as controls. As expected, MVF
expressed the endothelial cell marker CD31 (Fig 1C). In contrast to
the endothelial cells, they also strongly expressed the pericytic
marker protein a-SMA (Fig 1C). In line with these findings,
immunohistochemical analyses demonstrated that MVF still exhibit
the physiological morphology of native blood vessels, consisting of
an endothelium covered by a perivascular layer of a-SMA- and
platelet-derived growth factor receptor (PDGFR)-b-positive pericytes
(Fig 1D).
In a next step, we applied the liquid overlay technique to gener-
ate prevascularized islet organoids (Fig 1E). For this purpose, we
tested different time periods and ratios between MVF and MIN6 b-
cells to establish the ideal protocol for the formation of stable tissue
constructs of standardized size and shape. This was achieved by the
cocultivation of 2,000 MIN6 b-cells with 200 MVF for 5 days in
liquid overlay culture (Fig EV1A). Based on these promising results,
we generated PI + MVF out of primary pancreatic islet cells from
donor mice (Fig 1F). Pseudo-islets (PI) consisting of 2,000 islet cells
as well as freshly isolated islets (FI) and islets cultivated for 5 days
(CI) served as controls. FI, CI, and PI exhibited a comparable diame-
ter of ~ 160–170 µm (Fig EV1B). PI + MVF presented with a signifi-
cantly larger diameter of ~ 210 µm due to the incorporation of MVF
(Fig EV1B). Morphological scanning electron microscopic analysis
illustrated that PI + MVF are characterized by a heterogeneous
surface pattern, whereas the surface of PI and CI appears smooth
(Fig 1G). The surface of FI was rather rough (Fig 1G), most proba-
bly due to the fact that they were directly analyzed after the enzy-
matic isolation procedure, which may have caused disruption of the
outer cell layers.
Viability of prevascularized islet organoids
To assess whether the cells within PI + MVF were viable, we
performed neutral red and trypan blue stainings. We did not detect
any differences between PI + MVF, FI, CI, and PI (Figs 2A and
EV1C). More detailed flow cytometric analysis of propidium iodide/
annexin V-stained cells revealed a significantly higher number of
vital cells in PI + MVF (92  4%) when compared to CI (79  1%)
and PI (72  4%) (Fig 2B and C), indicating that MVF may have
beneficial effects on islet cell survival.
Long-term cultivation of islets for more than 2 days is known to
induce hypoxic stress (Giuliani et al, 2005), which leads to elevated
intracellular reactive oxygen species (ROS) levels (Ma et al, 2014)
and reduced b-cell viability (Cantley et al, 2010). To examine
whether MVF are able to lower ROS levels within islet organoids,
we next used islets from transgenic mice expressing the mitochon-
drial H2O2 biosensor mito-roGFP2-Orp1 (Fujikawa et al, 2016) for
PI + MVF generation. This biosensor is radiometric and changes its
fluorescence emission according to the ratio of oxidized (405 nm) to
reduced roGFP2 (488 nm), which depends on mitochondrial H2O2
Figure 1. Generation of PI + MVF.
A A neutral red-stained mouse pancreas is excised and digested with collagenase. Islets are then separated by hand picking and further digested into single islet cells.
Scale bars: 10 mm (left image); 200 µm (middle image); 60 µm (right image).
B Epididymal fat pads are isolated and processed mechanically and enzymatically. The obtained mixture, containing MVF and ECM, is filtrated for the purification of
MVF. Scale bars: 20 mm (left image); 25 µm (right image).
C Western blots of CD31, a-SMA, and GAPDH in whole cell extracts of eEND, HDMEC, HUVEC, and MVF.
D Immunofluorescence stainings of CD31/a-SMA and CD31/PDGFR-b in MVF. Cell nuclei are stained with Hoechst 33342 (blue). Scale bar: 20 µm.
E Schematic illustration of PI + MVF generation. By means of liquid overlay technique, 2,000 pancreatic islet cells and 200 MVF are cocultured for 5 days.
F PI and PI + MVF on days 5, 3, and 0. Scale bar: 200 µm.
G Surface morphology of FI, CI, PI, and PI + MVF on day 0 as visualized by scanning electron microscopy. Scale bar: 50 µm.
Source data are available online for this figure.
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levels (Fig 2D). In contrast to Giuliani and colleagues (Giuliani et al,
2005), we detected reduced ROS levels in CI when compared to FI
(Fig 2E), which may be explained by increased cellular stress during
the isolation procedure. Moreover, ROS levels in PI were higher
when compared to CI, indicating that the reaggregation process
during the generation of islet organoids rather than the cultivation
itself triggers ROS formation (Fig 2E). Of interest, MVF were capable
of protecting against this reaggregation-induced ROS formation
(Fig 2E). Additional Western blot analysis demonstrated that the
incorporation of MVF into islet organoids markedly increases the
expression of heme oxygenase (HO)-1 (Fig 2F and G), which is one
of the major ROS-scavenger enzymes in pancreatic b-cells (Pileggi
et al, 2001). To discriminate if endocrine or endothelial cells or both
express HO-1, we performed immunohistochemical analyses of
PI + MVF showing that HO-1 expression is mainly restricted to islet
cells (Fig 2H). This was verified by additional Western blot analyses
of PI and MVF (Fig 2I).
Cellular composition, endocrine function, and angiogenic activity
of prevascularized islet organoids
To investigate the cellular composition of FI, CI, PI, and PI + MVF,
we analyzed the fractions of insulin-, glucagon-, and somatostatin-
producing cells by means of immunohistochemistry (Fig 3A). In this
context, it should be noted that the endocrine cell number may dif-
fer between individual islets depending on their size. Moreover,
individual MVF also differ in their length and, thus, cellular content.
Most MVF used in this study exhibited a length of ~10–60 µm
(Fig EV1D). Due to these differences of cell numbers within individ-
ual islets and islet organoids, the data of the cellular composition
were normalized to the overall number of cells within FI, CI, PI, and
PI + MVF per section. Our quantitative analyses revealed a signifi-
cantly lower fraction of insulin-positive cells in CI, PI, and, in partic-
ular, in PI + MVF when compared to FI (Fig 3B). The latter finding
can be explained by the fact that the additional incorporation of
MVF markedly increases the overall cell number of the organoids
and, thus, reduces the fraction of insulin-positive cells. On the other
hand, we detected a lower fraction of glucagon-positive cells in FI
when compared to all cultivated groups (Fig 3C), which may be due
to the secretion of glucagon in low glucose-containing medium
during the hand picking procedure. We further determined a signifi-
cantly lower fraction of somatostatin-positive cells in PI + MVF
(Fig 3D).
In addition, we analyzed the expression and secretion of insulin
in FI, CI, PI, and PI + MVF by means of Western blot and enzyme-
linked immunosorbent assay (ELISA). We found that the prevascu-
larization of islet organoids with MVF does not affect the absolute
expression of the hormone (Fig 3E). However, the normalized
glucose-stimulated insulin secretion of PI + MVF was diminished
when compared to PI, most probably due to the incorporation of
MVF (Fig 3F). In contrast, the absolute insulin secretion and the
stimulatory index (SI) did not differ between PI and PI + MVF (Fig
EV1E and F).
We next investigated the microvasculature of islets and islet
organoids by immunohistological staining of CD31 (Fig 4A and
EV1G). We detected ~ 10% CD31-positive cells in FI (Fig 4B). In
line with previous studies reporting the progressive loss of endothe-
lial cells during islet cultivation (Parr et al, 1980; Mendola et al,
1994), both CI and PI exhibited a significantly lower fraction of
CD31-positive cells (Fig 4B). As expected, PI + MVF presented with
a markedly higher fraction of endothelial cells (Fig 4A and B, and
EV1H), as confirmed by additional Western blot analysis (Figs 4C
and D, and EV1I). Notably, these cells were clearly arranged in a
tube-like distribution pattern, corresponding to the incorporated
MVF within the constructs (Fig 4A). Three-dimensional confocal
microscopy of the prevascularized islet organoids further showed
the organization of these native microvessels into dense microvas-
cular networks in the center of the constructs and their surface
(Fig 4E). It should be noted that PI + MVF are not only composed
of endocrine and endothelial cells (Fig EV2A). This is because MVF
are fully functional native microvessels, which are covered with
stabilizing a-SMA-positive pericytes (Figs 1D, and EV2B). In addi-
tion, they also contain adipose stromal cells (ASC), a population of
pluripotent mesenchymal cells that is predominantly associated
with blood vessels (Traktuev et al, 2008). Accordingly, we detected
adipogenic differentiation in PI + MVF exposed to insulin for 5 days
(Fig EV2C).
Insulin binds to insulin receptor (IR) and insulin-like growth
factor receptor (IGFR) on endothelial cells, which stimulates their
proliferation (Shrader et al, 2009). We observed a high fraction of
68  5% Ki67-positive endothelial cells in PI + MVF (Fig 4F and
G). The stimulating effect of insulin on endothelial cell prolifera-
tion was verified by inhibition of IR/IGFR activity with the recep-
tor antagonist linsitinib, resulting in a markedly suppressed cell
proliferation within PI + MVF (Fig 4H). To elucidate the underly-
ing intracellular signaling induced by insulin, MVF were exposed
Figure 2. Viability of FI, CI, PI, and PI + MVF.
A Neutral red and trypan blue stainings of FI, CI, PI, and PI + MVF. CI incubated for 24 h with 0.2% H2O2 served as control. Scale bar: 100 µm.
B Representative flow cytometric scatterplots of propidium iodide/annexin V-stained cells from PI + MVF and CI + H2O2 (positive control).
C Quantitative analysis of propidium iodide/annexin V-stained cells from FI, CI, PI, PI + MVF, and CI + H2O2 subdivided in necrotic, necroptotic, apoptotic, and vital cells
in % of total cell number (n = 3 each).
D Schematic illustration of the mitochondrial ROS sensor mito-roGFP2-Orp1. The fluorescence maximum of this sensor shifts from 488 to 405 nm with increasing
mitochondrial H2O2 levels, as shown by representative fluorescence images of FI. Scale bar: 70 µm.
E Quantitative analysis of the ROS sensor ratio (405 nm/488 nm) of FI, CI, PI, and PI + MVF (n = 25 each). Mean  SD. One-way ANOVA and Tukey’s multiple
comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
F Representative Western blot analysis of b-actin and HO-1 in whole cell extracts from FI, CI, PI, and PI + MVF.
G Quantitative analysis of HO-1 expression in FI, CI, PI, and PI + MVF (n = 3 each). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were
used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
H Representative immunofluorescence stainings of HO-1/insulin and HO-1/CD31 in PI + MVF. Cell nuclei are stained with Hoechst 33342 (blue). Scale bar: 50 µm.
I Representative Western blot analysis of b-actin and HO-1 in whole cell extracts from PI and MVF.
Data information: Exact P-values are specified in Appendix Table S1.
◀
ª 2020 The Authors EMBO Molecular Medicine 13: e12616 | 2021 5 of 21
Lisa Nalbach et al EMBO Molecular Medicine
to insulin and the phosphorylation of extracellular-signal regu-
lated kinase (ERK)1/2 and Akt was determined by Western blot
(Fig 4I). Quantitative analysis showed increased levels of the two
phospho-proteins after insulin treatment (Fig 4J and K).
Moreover, we detected a higher expression of vascular endothelial
cell growth factor (VEGF)-A in PI + MVF, which may have also
promoted endothelial cell proliferation (Fig EV2D). We next inves-





Figure 3. Endocrine composition and function of FI, CI, PI, and PI + MVF.
A Representative immunofluorescence stainings of insulin/glucagon and insulin/somatostatin in FI, CI, PI, and PI + MVF. Cell nuclei are stained with Hoechst 33342
(blue). Scale bar: 60 µm.
B–D Quantitative analysis of insulin- (B), glucagon- (C) and somatostatin-positive cells (D) in FI, CI, PI, and PI + MVF in % of all islet or organoid cells (n = 20 each).
Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
E Western blot analysis of b-actin and insulin in whole cell extracts from FI, CI, PI, and PI + MVF.
F Insulin secretion (µU/ml) (normalized to DNA content) of FI, CI, PI, and PI + MVF exposed to 1.1 mM and 16.5 mM glucose (n = 3 each). Mean  SD. One-way
ANOVA and Tukey’s multiple comparisons post hoc test as well as an unpaired Student’s t-test were used for statistical analysis. *P < 0.05 vs. insulin secretion at
1.1 mM glucose within each individual group; +P < 0.05 vs. insulin secretion of PI at 16.5 mM glucose.
Data information: Exact P-values are specified in Appendix Table S1.
Source data are available online for this figure.
6 of 21 EMBO Molecular Medicine 13: e12616 | 2021 ª 2020 The Authors
EMBO Molecular Medicine Lisa Nalbach et al
organoids by means of collagen-based sprouting assays (Fig 4L).
Our results clearly demonstrate that in contrast to FI, CI, and PI
only cells from PI + MVF extensively sprouted into the surround-
ing matrix (Fig 4M). Additional immunohistochemical analyses
revealed that these cells partly stained for CD31, indicating their
endothelial nature (Fig 4L). Of note, this sprouting activity could
be further improved by exposing PI + MVF to high glucose
(Fig EV2E).
Generation of prevascularized humanized islet organoids
Based on our promising results using murine islets, we next investi-
gated whether it is also possible to generate humanized prevascular-
ized islet organoids. This would represent an important step toward
the translation of our novel approach into clinical practice. Human
pancreatic islets are isolated and processed in specialized islet isola-
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cultivated for 16–35 h before being distributed, which may require an
additional 3–5 day-period depending on the transportation distance.
As described above, the formation of prevascularized islet organoids
takes additional 5 days in liquid overlay culture (Fig 5A). Given these
circumstances, we could still show a successful incorporation of
murine MVF into human PI (hPI) (Fig 5B). Freshly delivered human
islets (hFI) as well as delivered human islets, which were cultivated
for additional 5 days (hCI), served as controls (Fig 5B). hFI, hCI, and
hPI exhibited a comparable diameter of ~ 165–180 µm, whereas
hPI + MVF presented with a significantly larger diameter of
~ 210 µm (Fig EV3A). Immunohistochemical stainings confirmed the
fusion of murine MVF and human endocrine islet cells into prevascu-
larized islet organoids, which contained a significantly higher fraction
of CD31-positive murine endothelial cells when compared to the
other groups (Fig 5C–G). As expected, we additionally detected a
substantial number of human endothelial cells in hFI (Fig EV3B and
C). Moreover, hPI + MVF were characterized by a similar vascular-
ization pattern when compared to murine islet organoids (Fig 4A and
5C). Accordingly, the humanized islet organoids also exhibited a
strong angiogenic activity, as indicated by a significantly increased
sprouting area in collagen-based sprouting assays when compared to
controls (Fig 5H and I). Of note, the incorporation of MVF into hPI
did not affect C-peptide secretion and C-peptide SI, which was compa-
rable to that of hFI (Figs 5J, and EV3D and E).
In vivo vascularization of prevascularized murine islet organoids
In a next set of experiments, we analyzed the in vivo vascularization
capacity of prevascularized islet organoids in the dorsal skinfold
chamber model (Fig 6A–H). For this purpose, we transplanted islets
and islet organoids of mouse origin onto the host striated muscle
tissue within dorsal skinfold chambers of syngeneic recipient mice
(Fig 6A and B). This approach guaranteed a physiological angio-
genic response to the grafts, which would have been markedly
affected when transplanting humanized islet organoids into
immunocompromised recipient animals. Using the dorsal skinfold
chamber model, we could repetitively analyze the vascularization of
the grafts on days 0 (i.e., day of transplantation), 3, 6, 10, and 14 by
means of intravital fluorescence microscopy (Fig 6A and D). This
technique did not only allow the quantitative assessment of
microvascular network morphology but also the measurement of
microhemodynamic parameters. The incorporation of MVF into PI
improved the take rate of the grafts, that is, the fraction of engrafted
islets or islet organoids in relation to the number of transplants per
group on day 14 (Fig 6C). In line with this result, we also found a
markedly accelerated and improved vascularization of PI + MVF
over time when compared to the other groups. In fact, application of
the blood plasma marker 5 % fluorescein isothiocyanate (FITC)-
labeled dextran revealed a significantly higher functional capillary
density of PI + MVF throughout the entire 14-day observation
period when compared to all control groups (Fig 6D and E). More-
over, they exhibited an increased revascularized area (Fig 6F). The
measurement of additional microhemodynamic parameters showed
that the blood-perfused microvessels within PI + MVF have also a
significantly larger diameter as well as a higher centerline red blood
cell velocity and volumetric blood flow on day 3 after transplanta-
tion (Fig EV4A–C). This markedly enhanced blood perfusion of the
islet organoids indicates that their rapid vascularization during the
early post-transplant period is rather driven by the interconnection
of MVF with the surrounding microvasculature than by the step-
wise angiogenic ingrowth of newly formed microvessels from the
host tissue, as it was the case for FI, CI, and PI.
We additionally measured the rhodamine 6G-positive area within
the grafts as a marker for blood-perfused and vital endocrine cells.
This fluorescent dye crosses the endothelial lining within islets and,
thus, stains the vessel-surrounding tissue (Diez et al, 2017). Of inter-
est, we found in line with our previous results a significantly higher
rhodamine 6G-positive area within PI + MVF throughout the entire
14-day observation period when compared to controls (Fig 6G and
H).
Figure 4. Microvasculature and angiogenic activity of CI, FI, PI, and PI + MVF.
A Representative immunofluorescence stainings of insulin and CD31 in CI, FI, PI, and PI + MVF. Cell nuclei are stained with Hoechst 33342 (blue). Scale bar: 100 µm.
B Quantitative analysis of CD31-positive cells in FI, CI, PI, and PI + MVF in % of all islet or islet organoid cells (n = 20 each). Mean  SD. One-way ANOVA and Tukey’s
multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
C Representative Western blot analysis of CD31 and b-actin in whole cell extracts from CI, FI, PI, and PI + MVF.
D Quantitative analysis of CD31 expression in FI, CI, PI, and PI + MVF in % of FI (n = 3). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test
were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
E Confocal microscopic images of CD31 and cell nuclei (blue) in PI + MVF, demonstrating endothelial cells (arrowheads). Scale bar: 100 µm.
F Representative immunofluorescence staining of Ki67 and CD31 in PI + MVF. Cell nuclei are stained with Hoechst 33342 (blue). Arrows mark endothelial cells
expressing Ki67. Scale bar: 100 µm.
G Quantitative analysis of CD31/Ki67-positive cells in FI, CI, PI, and PI + MVF in % of all endothelial cells (n = 10 each). Mean  SD. One-way ANOVA and Tukey’s
multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
H Flow cytometric analysis of BrdU-positive cells from PI + MVF treated with DMSO (vehicle) or linsitinib during the entire fusion process (n = 5 each). Mean  SD.
Unpaired Student’s t-test was used for statistical analysis. *P < 0.05 vs. vehicle.
I Representative Western blot analysis of pAkt, Akt, pERK1/2, and ERK1/2 from MVF cell extracts. MVF were treated with vehicle or insulin for 3 h.
J, K Quantitative analysis of pERK1/2/ERK1/2 (J) and pAkt/Akt (K) ratio in PI + MVF treated with vehicle or insulin for 3 h. Data are expressed as relative intensities (n = 3
each). Mean  SD. Unpaired Student’s t-test was used for statistical analysis. *P < 0.05 vs. vehicle.
L Representative bright field image of angiogenic sprouting from PI + MVF on day 3 of the sprouting assay. Scale bar: 150 µm. Insert: Immunofluorescence staining of
insulin (red) and CD31 (green) of sprouted PI + MVF. Cell nuclei are stained with Hoechst 33342 (blue). Scale bar: 30 µm.
M Quantitative analysis of sprouting area of FI, CI, PI, and PI + MVF in % of the initial size (day 0) (n = 10 each). Mean  SD. One-way ANOVA and Tukey’s multiple
comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
Data information: Exact P-values are specified in Appendix Table S1.
Source data are available online for this figure.
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Finally, we analyzed the expression of insulin, glucagon, somato-
statin, and CD31 by means of immunohistochemistry to characterize
the grafts’ cellular composition on day 14 after islet transplantation
(Fig 7A). We did not observe any differences in the relative fractions
of endocrine cells between all groups (Fig 7B–D). However, as
expected, PI + MVF presented with a significantly higher fraction of
intra-islet endothelial cells when compared to controls (Fig 7E). To
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endothelial cells, we transplanted additional islet organoids consisting
of GFP-positive MVF and GFP-negative islet cells into the dorsal skin-
fold chamber of GFP-negative recipient mice. The immunohistochem-
ical analysis of these grafts on day 14 revealed that 34  13% of the
CD31-positive endothelial cells within the grafts stained also positive
for GFP (Fig EV4D). This indicates that a substantial fraction of the
microvasculature within the grafts originated from the incorporated
MVF.
In vivo endocrine function of prevascularized islet organoids
Since we could show that prevascularized islet organoids exhibit
a strong angiogenic and vascularization capacity in vitro and
in vivo, we analyzed whether this may also result in an improved
restoration of normoglycemia in streptozotocin (STZ)-induced
diabetic animals. Sham-transplanted mice were used to demon-
strate the cytotoxic effect of STZ (Fig EV5A–F). STZ-treated mice
transplanted with FI served as positive control, whereas nondia-
betic animals served as negative controls. In order to define the
critical number of FI, which do not restore normoglycemia within
28 days, we transplanted 200, 250, 300, and 400 FI under the
kidney capsule of diabetic animals (Fig EV5G and H). Based on
these results, we transplanted a critical mass of 250 FI or 250
PI + MVF under the kidney capsule of diabetic mice (Fig 8A). The
body weights did not significantly differ between the groups over
the entire observation period (Fig 8B and C). Of note, in the
group of PI + MVF-transplanted mice we detected blood glucose
levels of 204  80 mg/dl already 4 days after transplantation
(Fig 8D). Moreover, normoglycemia was completely restored after
10 days (Fig 8D and E). In contrast, the transplantation of 250 FI
did not restore normoglycemia (Fig 8D and E). An intraperitoneal
glucose tolerance test (IPGTT) demonstrated that the blood
glucose levels of mice transplanted with PI + MVF were lower
when compared to animals transplanted with FI, resulting in a
significantly reduced AUC (Fig 8F and G). In contrast, the plasma
insulin levels, which were determined at 180 min after glucose
injection, did not differ between the groups (Fig 8H). At the end
of the in vivo experiments, the kidneys were harvested and the
grafts’ cellular composition was analyzed by means of immuno-
histochemistry (Fig 8I–K). This analysis revealed no differences in
the fraction of insulin-, glucagon-, somatostatin-, and CD31-
expressing cells between the two groups (Fig 8J). However, we
found a significantly higher overall number of islet cells per high
power field (HPF) in mice transplanted with PI + MVF when
compared to those receiving FI (Fig 8K). To further clarify
whether this was caused by an increased cell proliferation or the
inhibition of apoptosis, we analyzed Ki67 and cleaved caspase-3
(casp-3) stainings of the grafts (Fig EV5I). Of interest, we found a
Figure 6. In vivo vascularization of CI, FI, PI, and PI + MVF.
A Schematic illustration of the experimental setting: dorsal skinfold chambers are implanted on day 2 followed by transplantation of FI, CI, PI, and PI + MVF on day
0. Intravital fluorescence microscopy is performed on days 0, 3, 6, 10, and 14 after islet transplantation. On day 14, the tissue is harvested for immunohistochemical
stainings.
B Observation window of a dorsal skinfold chamber with eight neutral red-stained transplanted FI on day 0. Scale bar: 5 mm.
C Take rate (% of transplanted islets) on day 14 after islet transplantation into the dorsal skinfold chamber (n = 8 each). Mean  SD. One-way ANOVA and Tukey’s
multiple comparisons post hoc test were used for statistical analysis. +P < 0.05 vs. PI.
D Representative intravital fluorescent microscopic images of FI, CI, PI, and PI + MVF within the dorsal skinfold chamber on day 0 and 14. FITC-labeled dextran is
used for the visualization of blood-perfused microvessels. Grafts are marked by broken lines. Scale bar: 150 lm.
E, F Quantitative analysis of the functional capillary density (cm/cm2) (E) and revascularized area (mm2) (F) of transplanted FI, CI, PI, and PI + MVF on day 0, 3, 6, 10,
and 14 (n = 8 each). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs.
CI; +P < 0.05 vs. PI.
G Representative intravital fluorescent microscopic images of FI, CI, PI, and PI + MVF within the dorsal skinfold chamber on day 14. Rhodamine 6G is used to
visualize blood-perfused vital endocrine cells (bright signals). Scale bar: 150 µm.
H Quantitative analysis of the rhodamine 6G-positive area (% of islet size) within transplanted FI, CI, PI, and PI + MVF on day 0, 3, 6, 10, and 14. Mean  SD. One-
way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. CI; +P < 0.05 vs. PI.
Data information: Exact P-values are specified in Appendix Table S1.
▸
Figure 5. Generation of hPI + MVF.
A Schematic illustration of human islet isolation and delivery. Islets are isolated from human donors and cultivated for up to 35 h until they are delivered for the
generation of hPI + MVF. The entire process takes more than 8 days.
B Bright field images of hFI, hCI, hPI, and hPI + MVF. Scale bar: 100 µm.
C Representative immunohistochemical stainings of insulin and CD31 in hFI, hCI, hPI, and hPI + MVF. Cell nuclei are stained with Hoechst 33342 (blue). Scale bar:
100 µm.
D–G Quantitative analysis of insulin-(D), glucagon-(E), somatostatin-(F) and CD31-positive cells (G) in hFI, hCI, hPI, and hPI + MVF in % of all islet or islet organoid cells
(n = 20 each). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. hFI; #P < 0.05 vs. hCI;
+P < 0.05 vs. hPI.
H Representative bright field images of angiogenic sprouting of hFI, hCI, hPI, and hPI + MVF on day 3 of the sprouting assay. Scale bar: 150 µm.
I Quantitative analysis of sprouting area of hFI, hCI, hPI, and hPI + MVF in % of initial size (day 0; n = 10 each). Mean  SD. One-way ANOVA and Tukey’s multiple
comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. hFI; #P < 0.05 vs. hCI; +P < 0.05 vs. hPI.
J Quantitative analysis of C-peptide secretion (pg/ml; normalized to DNA concentration) of hFI and hPI + MVF exposed to 1.1 mM and 16.5 mM glucose (n = 3
each). Mean  SD.
Data information: Exact P-values are specified in Appendix Table S1.
Source data are available online for this figure.
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higher number of Ki67-positive cells in PI + MVF on day 3 after
transplantation when compared to FI (Fig EV5J). In contrast, we
only detected a few casp-3-positive apoptotic cells without any
significant differences between the two groups (Fig EV5K). These
results indicate that the incorporation of MVF into PI improves
the cell proliferation within the islet organoids during the initial
post-transplantation phase.
Taken together, our observations demonstrate that the fusion of
MVF and pancreatic islet cells to prevascularized islet organoids
significantly improves their in vivo vascularization, viability, and
functionality. Hence, prevascularized islet organoids represent
highly promising tissue constructs for clinical islet transplantation.
Discussion
Pancreatic islet transplantation is a promising strategy for the treat-
ment of T1D; however, the insufficient revascularization of the
grafts still represents a major problem. Common vascularization
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(Perez-Basterrechea et al, 2017) as well as on the incorporation of
epithelial and endothelial cells into islet organoids (Penko et al,
2011; Lebreton et al, 2019; Urbanczyk et al, 2020). However, the
development of blood vessels out of single cells requires up to
10 days and, thus, cannot prevent hypoxia-induced b-cell death
during the initial post-transplantation phase (Korsgren et al, 2005).
To overcome this problem, we herein introduce a novel concept of
islet prevascularization by the fusion of MVF with pancreatic islet
cells.
Previous studies reported that the generation of islet organoids
containing adipose-derived stem cells (ADSCs) or mesenchymal
stem cells (MSCs) results in separated spheroidal units after several
days of culture (Jun et al, 2014; Shin et al, 2015). This indicates that
the fusion of pancreatic islet cells with other cell types is difficult.
The fusion of MVF and pancreatic islet cells into stable tissue
constructs is even more challenging due to the heterogeneous size
and the multi-cellular composition of MVF. We found that the
successful fusion can be achieved by the combination of 2,000
mouse or human islet cells with 200 MVF. In this context, it should
be noted that pancreatic islets are characterized by a well-defined
composition of different endocrine cell types, allowing their commu-
nication and interaction for the control of blood glucose levels.
Importantly, we could show that the incorporation of MVF does not
affect this endocrine function.
It is controversially discussed whether freshly isolated or culti-
vated islets should be used for clinical islet transplantation.
Shapiro et al (2000) reported that grafted hFI are capable of induc-
ing normoglycemia in humans. However, it should be considered
that for logistic reasons the cultivation of isolated islets for several
hours is often hard to circumvent under clinical conditions. Of
interest, this seems not to be a major problem. In fact, Froud et al
(2005) found that the transplantation of hCI even results in an
improved clinical outcome when compared to hFI. Based on these
findings, we not only used PI but also FI and CI as controls in the
present study.
The cultivation of islets may trigger ROS formation, which
reduces their cellular viability (Cantley et al, 2010; Ma et al, 2014).
We herein detected an increased number of viable cells within
A
B C D E
Figure 7. Cellular composition of transplanted CI, FI, PI, and PI + MVF.
A Representative immunofluorescent stainings of insulin/glucagon, insulin/somatostatin and insulin/CD31 in FI, CI, PI, and PI + MVF on day 14 after transplantation.
Cell nuclei are stained with Hoechst 33342 (blue). Arrows mark intra-islet endothelial cells. Scale bar: 70 µm.
B–E Quantitative analysis of insulin- (B), glucagon- (C), somatostatin- (D), and intra-islet CD31-positive cells (E) within FI, CI, PI, and PI + MVF on day 14 after
transplantation (n = 10 each). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI;
#P < 0.05 vs. CI; +P < 0.05 vs. PI.
Data information: Exact P-values are specified in Appendix Table S1.
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PI + MVF when compared to controls. Therefore, we speculated
that MVF exhibit a protective activity against ROS. This hypothesis
was further supported by experiments using isolated islets from
mice expressing a mitochondrial ROS sensor for islet organoid
generation, which revealed that MVF protect against fusion-induced
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molecular mechanisms, we next analyzed HO-1 expression. We
found a markedly increased expression of this enzyme in b-cells of
PI + MVF, confirming a strong anti-oxidative activity of MVF in our
prevascularized islet organoids. The elevated HO-1 expression may
be explained by the hepatocyte growth factor (HGF)/c-Met signaling
pathway (Mellado-Gil et al, 2011). HGF is secreted by endothelial
cells and binds to its transmembrane tyrosine kinase receptor c-Met,
which is expressed in b-cells (Dai et al, 2005; Roccisana et al, 2005).
This interaction improves islet graft survival in diabetic animal
models (Garcia-Ocana et al, 2003). Recently, Chakraborty et al
(2019) reported that activated c-Met triggers anti-apoptotic protein
expression and exerts cytoprotective function against ROS genera-
tion via inducing HO-1 expression. Hence, it can be speculated that
MVF may induce HO-1 in b-cells by stimulation of the HGF/c-Met
pathway.
Our immunohistochemical analysis of PI + MVF did not only
show the rapid organization of MVF into dense microvascular
networks, but also a significantly higher number of proliferative
endothelial cells within prevascularized islet organoids when
compared to controls. This observation may be explained by the fact
that insulin promotes blood vessel formation via binding to
endothelial IR/IGFR (Wang et al, 2008; Liu et al, 2009; Escudero
et al, 2017). In line with this finding, we also detected a markedly
increased activity of the down-stream proliferating pathways Akt
and ERK1/2 in insulin-exposed MVF. Moreover, elevated glucose
levels further enhanced the angiogenic sprouting of PI + MVF. Inhi-
bition of IR/IGFR signaling, in turn, suppressed the proliferation of
endothelial cells within prevascularized islet organoids.
It should be noted that MVF are not only covered by stabilizing
a-SMA-positive cells but also by ASC, a population of pluripotent
mesenchymal cells that is predominantly associated with blood
vessels (Traktuev et al, 2008). In line with this observation, we
detected preadipocytes after exposure of PI + MVF to insulin. Trak-
tuev et al (2008) reported that the co-transplantation of ASC,
endothelial progenitor cells (EPC) and islets improve the formation
of neovessels. Furthermore, it is known that ASC protect trans-
planted islets from inflammatory cytokine-induced cell death (Song
et al, 2017). Hence, it can be assumed that the herein detected
progenitor cells may further support the angiogenic activity and
survival of prevascularized islet organoids.
By means of intravital fluorescence microscopy, we could
demonstrate that prevascularized islet organoids exhibit a signifi-
cantly accelerated and improved blood perfusion after transplan-
tation into dorsal skinfold chambers when compared to controls.
Additional immunohistochemical analysis of the grafts revealed
increased numbers of intra-islet endothelial cells within
PI + MVF, which have already been described to contribute to
the revascularization of pancreatic islets (Nyqvist et al, 2005).
Beside a rapid vascularization, the fenestration of the islet-asso-
ciated microvasculature is of major importance for endocrine
function (Hogan & Hull, 2017). It is well known that VEGF-A
triggers microvascular ingrowth and increases blood vessel
permeability after islet transplantation (Lammert et al, 2003;
Brissova et al, 2006). Of interest, we detected elevated VEGF-A
levels in prevascularized islet organoids, which may have stimu-
lated blood vessel fenestration and improves blood perfusion of
transplanted PI + MVF.
Based on these promising in vitro and in vivo results, we finally
analyzed whether the transplantation of prevascularized islet orga-
noids also results in an improved restoration of normoglycemia in
STZ-induced diabetic animals. We found that the transplantation of
a minimal mass of 250 PI + MVF rapidly normalizes blood glucose
levels within 7 days after transplantation, whereas 250 FI did not
restore normoglycemia during the entire observation period of
28 days. This result is of major importance considering the fact that
the donor to recipient ratio for clinical islet transplantation is still
4:1 to obtain insulin independence (Plesner & Verchere, 2011).
Hence, our novel data indicate that the transplantation of prevascu-
larized islet organoids may markedly reduce the number of donors
required for this therapeutic approach.
In a future clinical setting, MVF may be isolated from a diabetic
patient through enzymatic digestion of aspirated adipose tissue
according to standard operating procedures, as already reported for
the isolation of adipose tissue-derived stromal-mesenchymal cells
(Gimble et al, 2010). Because MVF exhibit an improved viability
due to shorter enzymatic digestion times and already represent fully
Figure 8. In vivo endocrine function of CI, FI, PI, and PI + MVF.
A Schematic illustration of the experimental setting: Diabetes is induced by a single injection of STZ 8 days before 250 FI or PI + MVF are transplanted under the
kidney capsule of diabetic mice (n = 7 each). Blood glucose level and body weight are measured from day 8 to day 28 twice a week. On day 28, blood samples and
kidney tissue are harvested for immunhistochemical stainings.
B Quantitative analysis of the body weight (g) of nondiabetic and diabetic mice transplanted with FI or PI + MVF from day 8 to day 28 (n = 7 each). Mean  SD.
C AUC of the body weight of nondiabetic and diabetic mice transplanted with FI or PI + MVF from day 0 to day 28 (n = 7 each). Mean  SD.
D Quantitative analysis of blood glucose level (mg/dl) of diabetic mice transplanted with FI or PI + MVF and nondiabetic controls from day 8 to day 28 (n = 7 each).
Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. PI + MVF.
E AUC of the blood glucose levels of diabetic mice transplanted with FI or PI + MVF and nondiabetic controls from day 0 to day 28 (n = 7 each). Mean  SD. One-way
ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. PI + MVF.
F Quantitative analysis of blood glucose level (mg/l) according to the IPGTT of diabetic mice transplanted with FI or PI + MVF and nondiabetic controls to the indicated
time points (n = 5 each). Mean  SD. One-way ANOVA and Tukey’s multiple comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI.
G AUC of IPGTT of diabetic mice transplanted with FI or PI + MVF and nondiabetic controls (n = 5 each). Mean  SD. One-way ANOVA and Tukey’s multiple
comparisons post hoc test were used for statistical analysis. *P < 0.05 vs. FI; #P < 0.05 vs. PI + MVF.
H Plasma insulin level (µU/ml) of diabetic mice transplanted with FI or PI + MVF and nondiabetic controls at 180 min after IPGTT (n = 4 each). Mean  SD.
I Representative immunofluorescent stainings of insulin/CD31 in FI and PI + MVF on day 28 after islet transplantation. Scale bar: 50 µm.
J Quantitative analysis of insulin- (b-cells), glucagon- (a-cells), somatostatin- (d-cells), and CD31-positive (endothelial) cells within transplanted FI and PI + MVF on
day 28 after islet transplantation. Data are expressed in % of total islet cells (n = 25). Mean  SD.
K Quantitative analysis of islet cells in transplanted FI and PI + MVF per HPF (n = 70 each). Mean  SD. Unpaired Student’s t-test was used for statistical analysis.
*P < 0.05 vs. FI.
Data information: Exact P-values are specified in Appendix Table S1.
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functional vessel segments, they may be even more effective than
such single cells (Später et al, 2020). The isolation of MVF should
be performed on the day of islet delivery to the islet transplant
center. Subsequently, MVF and the delivered islet cells may be fused
to prevascularized islet organoids in a hospital-associated facility
providing good manufacturing practices (GMP) conditions. For this
purpose, we introduce in the present study the liquid overlay tech-
nique, which allows a precise control of the organoids’ size by using
defined cell and MVF numbers. However, this technique is time-
consuming and, thus, may be difficult to implement into clinical
practice. Therefore, it will be necessary to establish novel high-yield
fabrication strategies for the generation of prevascularized islet
organoids of controlled size and composition. A promising step
toward this direction has recently been reported by Wassmer et al
(2020). They demonstrated that islet organoids can be easily
produced by the Sphericalplate 5DTM. This plate consists of 12 wells
with 750 micro cavities per well, which enables the generation of up
to 9,000 organoids per plate. The silicon molds of the plate allow
good intercellular contact regardless of the number of cells per
microwell, resulting in controlled spheroid sizes and composition.
Taken together, we demonstrate in this study that our novel strat-
egy for the generation of prevascularized islet organoids successfully
targets two of the three major obstacles of islet transplantation, that
is, (i) scarce donor supply and (ii) failed islet engraftment (Gamble
et al, 2018). To overcome the third drawback, that is, the need for
immunosuppressant therapy to prevent graft rejection (Gamble et al,
2018), our strategy may be extended by the fusion of insulin-produc-
ing cells originating from human embryonic stem cells (hESC) or
induced pluripotent stem cells (iPSC) with autologous MVF obtained
from liposuction. Finally, we feel that prevascularization by means of
MVF may have also great potential to improve the engraftment and
function of other tissue constructs, such as cerebral (Daviaud et al,
2018), intestinal (Cortez et al, 2018), hepatocyte-like (Pettinato et al,
2019), or thymus organoids (Fan et al, 2015).
Materials and Methods
Reagents and antibodies
All reagents and antibodies used in the present study are listed in
Tables EV1–EV3.
Cell culture
Primary human umbilical vein endothelial cells (HUVEC) and
human dermal microvascular endothelial cells endothelial cells
(HDMEC) were purchased from PromoCell. The cells were culti-
vated in Endothelial Cell Basal Medium at 37°C under a humidified
95–5% (v/v) mixture of air and CO2. The cells were passaged at a
split ratio of 1:3 after reaching confluence. The cells are regularly
tested for mycoplasma contamination.
Animals
Animals were maintained on a standard 12/12 h day/night cycle.
Water and standard pellet chow (Altromin, Lage, Germany) were
provided ad libitum. C57BL/6N wild-type and transgenic (Mito-
roGFP2-Orp1) (Fujikawa et al, 2016) mice with an age of 8–
10 weeks and a body weight of 25–30 g served as donors for
islet isolation. Male C57BL/6N wild-type mice and C57BL/6-Tg
(CAG-EGFP)1Osb/J mice (purchased from Charles River) with a
body weight of 30–35 g served as donors for MVF isolation.
Diabetes was induced in 6- to 8-week-old male C57BL/6N wild-
type mice.
All experiments were performed according to the German legisla-
tion on protection of animals and the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources, National Research Council, Wash-
ington DC, USA). The experiments were approved by the local
governmental animal protection committee (permission number:
18/2017 and 45/2018).
Isolation of pancreatic islets
Mouse pancreatic islets were isolated by collagenase-induced enzy-
matic digestion and purified by hand picking, as described previ-
ously in detail (Li et al, 2009). Isolated islets were cultivated in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, and
0.1 mg/ml streptomycin at 37°C and 5% CO2 for further experi-
ments.
Isolation of MVF
Microvascular fragments were isolated by mechanic and enzymatic
digestion of epididymal fat pads of mice, as described previously in
detail (Frueh et al, 2017b). Briefly, mice were anesthetized and the
epididymal fat pads were harvested through a midline laparotomy.
Subsequently, the fat pads were washed in PBS and digested in
collagenase NB4G (0.5 U/ml PBS) for 10 min under vigorous stir-
ring at 37°C. The digestion was stopped by adding DMEM supple-
mented with 10% (v/v) FBS, 100 U/ml penicillin, and 0.1 mg/ml
streptomycin. MVF were separated from the fat layer by gravity and
filtration through a 500 µm filter and washed twice by centrifuga-
tion at 600 g for 5 min at room temperature. We obtained ~ 1 ml fat
per mouse, resulting in ~ 40,000 MVF. Finally, the MVF pellet was
resuspended in DMEM and the isolated MVF were counted before
combining them with islet cells. After isolation, MVF were culti-
vated in DMEM supplemented with 10% (v/v) FBS, 100 U/ml peni-
cillin, and 0.1 mg/ml streptomycin at 37°C and 5% CO2 for further
experiments.
Generation of PI
Isolated islets were dispersed into single cells by incubation in
0.05% (w/v) trypsin-ethylenediaminetetraacetic acid (EDTA) for
20 s. The enzymatic dispersion was stopped by the addition of
DMEM supplemented with 10% (v/v) FBS, 100 U/ml penicillin,
and 0.1 mg/ml streptomycin. PI were generated by means of the
liquid overlay technique in 96-well plates covered with 1%
agarose. The wells were equilibrated with culture medium for 1 h
at 37°C prior cell seeding. Murine islets consist of ~ 1,500 cells
and human islets of ~ 2,200 cells. In this study, we used 2,000
islet cells for the generation of PI and PI + MVF as well as hPI and
hPI + MVF, because cell loss during organoid generation cannot
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be excluded. In a next step, 2,000 islet cells were seeded per well
and cultivated for 5 days. To form PI + MVF, 2,000 islet cells were
cocultured with 200 MVF. The culture medium was changed every
second day. After 5 days of cultivation at 37°C and 5% CO2, the
organoids were harvested and their diameters were measured by
analyzing light microscopic images using FIJI software (NIH,
Bethesda, MD, USA).
Human samples
Islets were isolated from donor organs were obtained with informed
written consent and research ethics approval at the University of
Alberta (Pro00013094, Pro00001754). Experiments conformed to the
principles set out in the WMA Declaration of Helsinki and the
Department of Health and Human Services Belmont Report. Human
islets were cultured in low-glucose (5.5 mmol/l) DMEM with L-
glutamine, 110 mg/l sodium pyruvate, 10% FBS, and 100 units/ml
penicillin/streptomycin.
Immunohistochemistry
Islet organoids, CI and FI (embedded in HepatoQuick clots), mouse
pancreata and kidneys with transplanted islets were fixed for 24 h
in 4% paraformaldehyde (PFA) at 4°C. After dehydration, the paraf-
fin-embedded samples were cut into 3-lm-thick sections. The trans-
planted islets within the kidney capsules were cut sequentially and
every 10th slice was immunohistochemically evaluated. Antigens in
samples were demasked by citrate buffer and the unspecific binding
sites were blocked by goat serum. Cells were stained by incubation
with specific primary antibodies against insulin (1:300), glucagon
(1:300), somatostatin (1:300), CD31 (1:300), Ki67 (1:200), casp-3
(1:200), and a-SMA (1:500), which were detected by the corre-
sponding secondary antibodies (goat-anti-rabbit-cyanine (Cy)3;
goat-anti-mouse-Cy3; goat-anti-rat-Cy3; goat-anti-rat-Alexa Fluor
555, goat-anti-rabbit-streptavidin-peroxidase). Cell nuclei were
stained with Hoechst 33342. The sections were analyzed using a
BX60F fluorescence microscope (Olympus). The quantification of
positively stained cells was done by FIJI software (NIH) and is given
in % of all islet cells.
Mitochondrial H2O2 sensor detection
Islet organoids, CI, and FI were collected and immediately immersed
in phosphate-buffered saline (PBS) containing freshly dissolved
100 mM N-ethylmaleimide (NEM) for 20 min at 4°C. Then, the
organoids were fixed for 30 min in 4% PFA at 4°C and embedded in
HepatoQuick. After dehydration and paraffin embedding, samples
were cut into 3-lm-thick sections and sealed with a cover glass.
Microscopic images were taken within 24 h after mounting. Guideli-
nes for the microscopy settings and image analysis of roGFP2-based
redox probes have been described previously (Fujikawa et al, 2016).
Briefly, fluorescence images were acquired by measuring emission
at 520–540 nm and exciting sequentially with the 405 and 488 nm
laser lines using a 20× objective. For further analysis, images were
exported to FIJI software and the ratio between both sensor’s
images were created by dividing the 405 nm image by the corre-
sponding 488 nm image pixel by pixel. Data are represented as
normalized fluorescence ratios (405/488 nm).
Scanning electron microscopy
The surface topography of islet organoids, CI, and FI was character-
ized by scanning electron microscopy, as described previously in
detail (Laschke et al, 2016). Briefly, islet organoids, CI, and FI were
washed twice in PBS and fixed in 2% (v/v) glutardialdehyde in
0.1 M sodium cacodylate buffer for 10 min at room temperature
(RT). The islets were incubated in osmium tetroxide (1% (v/v) in
0.2 M sodium cacodylate buffer) for 1 h in the dark and dehydrated
by incubation in an ethanol series. After sputtering, the dried
samples were transferred to conductive carbon adhesive tabs and
analyzed in a FEI XL 30 ESEM FEG scanning electron microscopic
device (FEI, Hillsboro, OR).
Western blot analysis
For the preparation of cell lysates, islet organoids, CI, and FI were
lysed for 30 min at 4°C in radioimmunoprecipitation assay buffer
(Thermo Scientific, Bremen, Germany) containing 0.5 mM phenyl-
methylsulfonyl fluoride (PMSF) and a protease inhibitor cocktail
(1:75 v/v; Sigma-Aldrich). Proteins were separated through a 10%
sodium dodecyl sulfate (SDS)–polyacrylamide gel and transferred
onto a polyvinylidene fluoride (PVDF) membrane. The membrane
was blocked with 5% dry milk in PBS (0.1% Tween 20) for 1 h and
then incubated with specific antibodies (anti-CD31 antibody [1:100],
anti-a-SMA antibody [1:100], anti-phosphorylated (p)AKT1/2/3
antibody [1:100], anti-AKT antibody [1:500], anti-ERK antibody
[1:500], anti-pERK antibody [1:500], anti-HO-1 antibody [1:100],
anti-insulin antibody [1:500], anti-GAPDH antibody [1:1,000], or
anti-b-actin antibody [1:2,000]). Subsequently, the membrane was
washed and incubated for 1 h with the corresponding horseradish
peroxidase (HRP)-conjugated secondary antibodies (anti-rabbit anti-
body [1:1,000], anti-goat antibody [1:2,000], or anti-mouse antibody
[1:1,500]). The protein expression was visualized by the incubation
of the membrane with enhanced chemoluminescence (ECL)
Western blotting substrate (GE Healthcare) in a Chemocam device
(Intas). The intensity of the measured signals was quantified using
ImageJ software and normalized by the corresponding housekeep-
ing protein.
Neutral red and trypan blue staining
Islet organoids, CI, and FI (n = 20 each) were incubated for 2 min
at RT with neutral red (1:100) or trypan blue (1:100) and washed
with PBS. The cellular stainings were visualized by bright field
images using a 20× objective of BX60 microscope (Olympus).
Propidium iodide/annexin V and BrdU staining
Islet organoids, CI, FI, and FI cultivated for 24 h in 0.2% H2O2
were dispersed into single cells by accutase (1:20). Subsequently,
the cells were washed in PBS, resuspended in incubation buffer,
and stained for 15 min with propidium iodide and annexin V
(100 lg/ml), according to the manufacturer’s protocol (Roche).
The stained cells were analyzed by flow cytometry using
FACScan (BD Biosciences) and the amount of vital, apoptotic,
necrotic as well as necroptotic cells were given in % of all
measured cells.
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For BrdU staining, PI + MVF were cultivated for 5 days in liquid
overlay technique in the presence of 10 µM BrdU and 800 mM linsi-
tinib or dimethylsulfoxide (DMSO). Afterward, PI + MVF were
dispersed and fixed in 70% ethanol for 30 min on ice. The BrdU-
FITC stained cells were analyzed by flow cytometry according to the
manufacturer’s protocol (BD Biosciences).
Insulin/C-peptide ELISA
The amount of secreted insulin/C-peptide was measured in vitro as
described previously in detail (Kelly et al, 2010). Briefly, 10 islet
organoids, CI or FI were washed with Krebs Ringer buffer (KRB;
115 mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM MgSO4, 0.1%
BSA, 1.1 mM glucose) and incubated for 40 min at 37°C and 5%
CO2. The supernatants were collected, and the islets were addition-
ally incubated for 20 min in KRB containing 16.5 mM glucose. The
supernatants were collected again, and the amount of secreted
insulin was determined by using an insulin or C-peptide ELISA kit
according to the manufacturer’s protocol. The data were normalized
to the corresponding DNA concentration of islets and islet orga-
noids. For this purpose, islets and islet organoids were harvested
after glucose-stimulated insulin secretion and the DNA was isolated
by using the PureLink Genomic DNA kit according to the manufac-
turer’s protocol. The DNA concentration was measured by means of
a NanoDrop. The SI was calculated by dividing the mean DNA
normalized insulin values measured from the high and low glucose
samples.
Sprouting assay
Islet organoids, CI, and FI were collected and resuspended in a
collagen solution to transfer them into pre-warmed 24-well plates,
as previously described (Heiss et al, 2015). After 45 min, DMEM
supplemented with 10% (v/v) FBS, 100 U/ml penicillin and
0.1 mg/ml streptomycin was added and PI + MVF, PI, CI, and FI
were incubated for 72 h at 37°C and 5% CO2. Their sprouting
capacity was analyzed by measuring the sprouting area by FIJI
software (NIH). Data are given in % of the initial spheroid area
(day 0).
Preparation of the dorsal skinfold chamber and transplantation
of PI + MVF, PI, CI, and FI
The dorsal skinfold chamber was prepared, as described previously
in detail (Laschke et al, 2011). Briefly, two symmetrical titanium
frames were implanted on the extended dorsal skinfold of anes-
thetized mice, resulting in the doubling of the skin in two layers.
One layer, including skin, subcutis, and the retractor muscle, was
completely removed in a circular area of 15 mm in diameter. This
area was then covered by a removable cover slip and snap ring,
providing direct microscopic access to the microcirculation of the
chamber. After the procedure, the animals were allowed to recover
for 72 h.
After recovery, the cover glass was removed and the tissue
washed with saline. Subsequently, eight islet organoids, CI, or FI
were transplanted onto the exposed striated muscle tissue. Finally,
the chamber was sealed with a new cover slip for further intravital
fluorescence microscopic analysis.
Intravital fluorescence microscopy
Dorsal skinfold chamber-equipped mice were anesthetized and
received a retrobulbary, intravenous injection of 0.05 ml FITC-
labeled dextran (5%) for plasma staining and 0.05 ml rhodamine
6G (2%) for the visualization of blood-perfused and vital endocrine
cells (Vajkoczy et al, 1995) on day 0 as well as 3, 6, 10, and 14 after
islet transplantation. After this injection, the dorsal skinfold cham-
ber was positioned under a fluorescence microscope (Zeiss) with a
100 W mercury lamp attached to a blue (excitation wavelength:
450–490 nm/emission wavelength: > 515 nm) and a green (530–
560 nm/> 585 nm) filter block. The microscopic data were recorded
by a charge-coupled device video camera (FK6990; Pieper), trans-
ferred to a monitor (Trinitron) and a DVD system (DVD-HR775;
Samsung) for off-line evaluation.
Microscopic images were analyzed off-line by the computer-
assisted image analysis system CapImage (Zeintl, Heidelberg,
Germany). The islet size (mm2), the revascularized area (mm2), the
functional capillary density (cm/cm2), and the rhodamine 6G-posi-
tive area of the islets were assessed as previously described (Menger
et al, 1992; Ampofo et al, 2015). In addition, we measured the diam-
eter (µm), centerline RBC velocity (µm/s), and volumetric blood
flow (pl/s) of 4–8 individual microvessels within the grafts (Menger
et al., 1992; Ampofo et al, 2015). Moreover, we determined the take
rate (%), that is, the fraction of engrafted islets in relation to the
number of transplanted islets per group on day 14. Successful
engraftment was defined as the presence of a newly formed islet-
associated blood vessel network.
Diabetes induction and allogenic islet transplantation
Diabetic phenotypes were induced by a single intraperitoneal injection
of 180 mg/kg STZ 8 days prior to islet transplantation. Body weight
and non-fasting blood glucose levels of STZ-injected mice were
measured twice a week. Blood samples were taken from the tail vein
and analyzed by a portable blood glucose monitoring system (GL50;
Breuer). Mice with a non-fasting blood glucose level ≥ 350 mg/dl
served as recipients for islet transplantation (Sakata et al, 2012). Four
hundred FI, 300 FI, 250 FI, 200 FI, and 250 PI + MVF were injected
under the kidney capsule of diabetic mice using a 10 µl Hamilton
syringe, as described previously in detail (Menger et al, 2020). Blood
glucose levels and body weight were monitored over the entire obser-
vation period of 28 days twice a week. Normoglycemia was defined
by blood glucose levels below 200 mg/dl.
IPGTT
Intraperitoneal glucose tolerance test was performed 4 weeks after
islet transplantation under the kidney capsule of diabetic mice as
previously described (Noguchi et al, 2012). Briefly, after 16 h of fast-
ing, the mice were intraperitoneally injected with a 10% glucose solu-
tion and their blood glucose levels were determined 0, 15, 30, 45, 60,
120, and 180 min after glucose injection from the tail vein and
analyzed by a portable blood glucose monitoring system (GL50;
Breuer). Thereafter, the mice were anesthetized and the blood
samples were collected from the vena cava. The blood plasma was
separated by centrifugation and stored at 80°C. The plasma insulin
levels were analyzed by means of an insulin ELISA (Invitrogen, USA).
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Oil Red O staining
Prevascularized islet organoids were seeded on cell culture dishes
and cultivated for 5 days in DMEM supplemented with 2 µM
insulin, 10% (v/v) FBS, 100 U/ml penicillin, and 0.1 mg/ml strepto-
mycin. Subsequently, the attached organoids were washed with PBS
and fixed in 10% formalin at RT for 1 h. Organoids were incubated
for 5 min in 60% isopropanol at RT and incubated for 1 h with fil-
tered Oil Red O working solution (60% isopropanol, 8 mg Oil Red
O). Bright field images were acquired by means of a BX60 micro-
scope (Olympus) using a 40× objective.
Real-time quantitative-polymerase chain reaction
Total RNA was isolated using QIAzol lysis reagent (Qiagen). The
corresponding cDNA was synthesized from 1 lg of total RNA by
QuantiNova Reverse Transcription Kit (Qiagen) according to the
manufacturer’s instructions. ORA qPCR Green ROX L Mix (highQu)
was used for Real-time quantitative-PCR. The data analysis was
performed by the MiniOpticon Real-Time PCR System (Bio-Rad).
Murine b-actin served as internal control for mRNA detection.
Forward and reverse primers were used in a concentration of
700 nM solved in RNase/DNase-free H2O. Primer sequences for
qPCR were coded as follows: VEGF-A forward 50-GCTGTACCTC
CACCATGCCAAG-30, reverse 50-CGCACTCCAGGGCTTCATCG-30; b-
actin forward 50-CCTAGGCACCAGGGTGTGAT-30, reverse 50-TCTCC
ATGTCGTCCCAGTTG30.
Statistical analysis
All in vitro experiments were reproduced at least three times. For
in vivo studies, we used at least five animals per group and no mice
were excluded from the statistical analysis. After testing the data for
normal distribution and equal variance, differences between two
groups were assessed by the unpaired Student’s t-test. To test dif-
ferences between multiple groups, one-way ANOVA was applied.
This was followed by the Tukey post hoc test by means of Prism
software 8 (GraphPad). All values are expressed as Mean  SD.
Statistical significance was accepted for P < 0.05.
Data availability
This study includes no data deposited in external repositories.
Expanded View for this article is available online.
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